ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has engaged leading strategic consulting firm QUILT Solutions giving the company access to significant experience, business development, sales and marketing expertise in lucrative European markets.
